CardioComm Solutions, Inc.
EKG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 390.60K | 475.70K | 542.80K | 649.80K | 696.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 390.60K | 475.70K | 542.80K | 649.80K | 696.30K |
| Cost of Revenue | 22.50K | 29.30K | 33.50K | 94.50K | 172.00K |
| Gross Profit | 368.10K | 446.40K | 509.30K | 555.30K | 524.30K |
| SG&A Expenses | 577.70K | 633.40K | 643.90K | 640.40K | 562.20K |
| Depreciation & Amortization | 19.40K | 18.40K | 17.80K | 18.10K | 20.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 619.60K | 681.00K | 695.10K | 753.00K | 754.80K |
| Operating Income | -229.00K | -205.40K | -152.40K | -103.30K | -58.60K |
| Income Before Tax | -138.00K | -103.50K | -49.80K | -71.80K | -50.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.14 | -0.10 | -0.05 | -0.07 | -0.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.00K | -103.50K | -49.80K | -71.80K | -50.50K |
| EBIT | -229.00K | -205.40K | -152.40K | -103.30K | -58.60K |
| EBITDA | -227.40K | -203.50K | -149.90K | -99.10K | -53.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 642.49M | 604.68M | 604.68M | 604.52M | 604.30M |
| Average Diluted Shares Outstanding | 642.49M | 604.68M | 604.68M | 604.52M | 604.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
